The fully-loaded cost of bringing a new drug to market exceeds $2 billion in 2026, with clinical failure accounting for the majority of that cost. AI addresses the economics of drug development by improving target selection early in the pipeline, optimizing trial design to improve success rates, and accelerating the regulatory documentation work that adds time without adding science.
Six AI pharmaceutical workflows
Drug Discovery
Analyzes molecular structures, protein interactions, and biological pathway data to identify promising drug candidates and predict clinical failure modes earlier in the discovery cycle — reducing the research investment that reaches expensive late-stage failure. ↑40% hit-to-lead conversion rate and ↓30% discovery phase duration from AI-assisted target identification and compound screening.
Clinical Trial Optimization
Optimizes trial design, patient recruitment, site selection, and protocol adherence monitoring — identifying the patient populations, sites, and endpoints most likely to generate statistically significant results within trial timelines. ↓25% clinical trial duration from AI-optimized recruitment and adaptive trial design versus standard protocol development and enrollment approaches.
Regulatory Document Preparation
Accelerates regulatory submission preparation — generating CTD sections, literature review summaries, clinical study reports, and response-to-agency documents from structured clinical data — reducing the time from data lock to regulatory submission that currently constrains launch timelines. ↓50% regulatory writing time per submission package.
Pharmacovigilance
Monitors adverse event data from clinical trials, post-market surveillance, literature, and social media — identifying safety signals that require regulatory reporting and product labeling updates. ↓60% case processing time per individual case safety report (ICSR) while maintaining the signal detection sensitivity that product safety programs require under 21 CFR Part 314 and ICH E2E guidelines.
Medical Affairs
Supports medical affairs field teams with AI-generated literature summaries, scientific exchange support, and medical information response drafting — enabling medical science liaisons to engage more deeply with healthcare professional stakeholders while maintaining the medical accuracy and compliance standards that medical affairs communications require.
Supply Chain Management
Manages pharmaceutical supply chain complexity — demand forecasting for marketed products, clinical supply planning for active trials, cold chain compliance monitoring, and serialization tracking — reducing the stockout and expiry events that interrupt patient access and generate regulatory compliance exposure for commercial pharmaceutical operations.